{
    "Clinical Trial ID": "NCT00880022",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Arm Compression Only",
        "[Not Specified]",
        "INTERVENTION 2: ",
        "  Arm, Trunck and Chest Compression",
        "[Not Specified]"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Individuals at least six months post- surgery and/or radiation treatment for breast cancer",
        "  At least 21 years of age",
        "  Lymphedema in one arm subsequent to breast cancer treatment with coexisting truncal swelling ** (Part One) and *lymphedema in one arm subsequent to breast cancer treatment without coexisting truncal swelling (Part Two)",
        "  Willing and able to drive to the study site as needed",
        "  Currently not using a compression pump or undergoing manual lymphatic drainage by a therapist",
        "Exclusion Criteria:",
        "  Actively undergoing or less than six months post intravenous chemotherapy or radiation therapy",
        "  Individuals with congestive heart failure, chronic/acute renal disease, cor pulmonal, nephrotic syndrome, nephrosis, liver failure or cirrhosis, pulmonary edema, thrombophlebitis, deep vein thrombosis, infection of any kind and inflammation (redness) in the trunk or arms",
        "  History of bilateral breast cancer",
        "  Metastatic cancer",
        "  Inability to stand upright",
        "  Metal implants that would interfere with bioimpedance measurement equipment",
        "  Pregnancy",
        "  Pacemaker and internally implanted defibrillators"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Arm Volume at End of Study",
        "  measured by tape and then volume was calculated.",
        "  Time frame: end of scheduled treatments-day 30 of treatment",
        "Results 1: ",
        "  Arm/Group Title: Arm Compression Only",
        "  Arm/Group Description: [Not Specified]",
        "  Overall Number of Participants Analyzed: 21",
        "  Median (Inter-Quartile Range)",
        "  Unit of Measure: ml  2376.52        (1934.68 to 2622.99)",
        "Results 2: ",
        "  Arm/Group Title: Arm, Trunck and Chest Compression",
        "  Arm/Group Description: [Not Specified]",
        "  Overall Number of Participants Analyzed: 21",
        "  Median (Inter-Quartile Range)",
        "  Unit of Measure: ml  2539.93        (2168.28 to 3295.97)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/21 (0.00%)",
        "Adverse Events 2:",
        "  Total: 0/21 (0.00%)"
    ]
}